首页>投融资
Nanalysis Scientific
上市后再融资
Nanalysis Scientific Corp.是一家垂直整合的全球科学仪器制造商,开发和销售专有的台式核电设备。该公司是紧凑型磁共振成像和光谱产品的全球制造商和销售商。NMReady-60™是2013年市场上发布的第一款便携式高分辨率60 MHz台式NMR光谱仪。
基本信息
-
公司全称Nanalysis Scientific Corp
-
类型紧凑型磁共振成像和光谱产品制造、销售商
-
产业领域医疗器械
-
公司人数不明确
-
地址Bay 1, 4600-5 Street NE
-
联系电话1-855667-3239
-
邮箱sales@nanalysis.com
-
成立时间2009-01-01
投融资
-
2023-04-21上市后再融资350万美元未透露
-
2022-03-17上市后再融资498.5万美元未透露
-
2022-02-11增发1522.47万美元未透露
-
2020-04-16上市未透露未透露
-
2018-11-20上市后再融资270万美元Western Innovation (WINN) Initiative
-
2018-01-15上市后再融资10万美元Brisio Innovations
-
2017-06-30上市未透露未透露
- 加载更多
相关投融资企业
C轮
Francis Medical is a dynamic medical device company committed to developing urological cancer treatments that are tough on cancer yet gentle on patients.In September 2020, Coloplast announced that it has completed a USD 4m (DKK 25m) equity investment in Francis Medical
收并购
Gynesonics is a developer of transcervical, uterus-preserving, incision-free technologies for diagnostic and therapeutic applications (avoiding invasive surgical techniques of hysterectomy or myomectomy for symptomatic uterine fibroids). Products include the Sonata system which combines intrauterine ultrasound guidance with targeted radiofrequency ablation.In April 2023, the company closed a financing round of $25M
未公开
PBS Biotech 是一次性生物反应器系统的领先制造商。PBS 生物反应器利用专有的“Vertical-Wheel TM ”技术来支持剪切敏感的细胞治疗产品。PBS Biotech愿景是成为世界上同种异体细胞疗法的标准制造平台。